What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Disease
His primary areas of study are Internal medicine, Endocrinology, Prospective cohort study, Risk factor and Surgery.
His Endocrinology study integrates concerns from other disciplines, such as Genotype and Comorbidity.
His research integrates issues of Gerontology, Cohort study, Hazard ratio, Subclinical infection and Pediatrics in his study of Prospective cohort study.
His Risk factor research also works with subjects such as
- Cause of death which intersects with area such as Risk of mortality,
- Statin most often made with reference to Clinical trial.
His study in Surgery is interdisciplinary in nature, drawing from both Diabetes mellitus, Framingham Risk Score, Pravastatin and Confidence interval.
His work focuses on many connections between Confidence interval and other disciplines, such as Epidemiology, that overlap with his field of interest in Longevity.
His most cited work include:
- Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial (2750 citations)
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials (1677 citations)
- Genetic influence on cytokine production and fatal meningococcal disease (725 citations)
What are the main themes of his work throughout his whole career to date?
Rudi G. J. Westendorp spends much of his time researching Internal medicine, Endocrinology, Gerontology, Prospective cohort study and Longevity.
His Internal medicine research integrates issues from Surgery and Cardiology.
His Gerontology research is multidisciplinary, incorporating perspectives in Cognition, Activities of daily living, Dementia, Cognitive decline and Ageing.
His Prospective cohort study research incorporates themes from Myocardial infarction, Subclinical infection, Cohort study and Risk factor.
Longevity is a subfield of Genetics that Rudi G. J. Westendorp explores.
Rudi G. J. Westendorp has researched Hazard ratio in several fields, including Stroke and Proportional hazards model.
He most often published in these fields:
- Internal medicine (45.90%)
- Endocrinology (22.49%)
- Gerontology (17.48%)
What were the highlights of his more recent work (between 2014-2021)?
- Internal medicine (45.90%)
- Endocrinology (22.49%)
- Gerontology (17.48%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Endocrinology, Gerontology, Confidence interval and Cohort study.
His work on Cardiology expands to the thematically related Internal medicine.
As a part of the same scientific study, Rudi G. J. Westendorp usually deals with the Endocrinology, concentrating on Offspring and frequently concerns with Longevity.
His Confidence interval research is multidisciplinary, relying on both Proportional hazards model and Confounding.
His studies deal with areas such as Longitudinal study, Epidemiology, Cohort and Geriatrics as well as Cohort study.
His Prospective cohort study research focuses on Pravastatin and how it relates to Physical therapy.
Between 2014 and 2021, his most popular works were:
- HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials. (405 citations)
- Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism. (179 citations)
- Subclinical thyroid dysfunction and fracture risk: A meta-analysis (148 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Disease
His primary scientific interests are in Internal medicine, Gerontology, Endocrinology, Hazard ratio and Prospective cohort study.
His Gerontology research includes elements of Quality of life, Activities of daily living, Cognitive decline, Mental health and Comorbidity.
The various areas that Rudi G. J. Westendorp examines in his Endocrinology study include Offspring and Longevity.
Rudi G. J. Westendorp interconnects Survival analysis and Disease in the investigation of issues within Hazard ratio.
His Prospective cohort study research is multidisciplinary, incorporating elements of Stroke and Pravastatin.
His study focuses on the intersection of Cohort study and fields such as Cohort with connections in the field of Surgery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
